AIM
Anchor Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40
| Closed | -$1.63K | – | 985 |
|
|
2022
Q4 | $1.63K | Sell |
40
-100
| -71% | -$4.07K | ﹤0.01% | 882 |
|
|
2022
Q3 | $9.15K | Hold |
140
| – | – | ﹤0.01% | 730 |
|
|
2022
Q2 | $8.51K | Hold |
140
| – | – | ﹤0.01% | 756 |
|
|
2022
Q1 | $8.79K | Hold |
140
| – | – | ﹤0.01% | 772 |
|
|
2021
Q4 | $10.6K | Buy |
140
+100
| +250% | +$7.58K | ﹤0.01% | 778 |
|
|
2021
Q3 | $4.48K | Hold |
40
| – | – | ﹤0.01% | 795 |
|
|
2021
Q2 | $6.48K | Hold |
40
| – | – | ﹤0.01% | 775 |
|
|
2021
Q1 | $4.87K | Hold |
40
| – | – | ﹤0.01% | 785 |
|
|
2020
Q4 | $6.12K | Hold |
40
| – | – | ﹤0.01% | 725 |
|
|
2020
Q3 | $3.35K | Hold |
40
| – | – | ﹤0.01% | 766 |
|
|
2020
Q2 | $2.94K | Buy |
+40
| New | +$2.94K | ﹤0.01% | 753 |
|